Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 3
2002 5
2003 1
2004 7
2005 9
2006 10
2007 10
2008 10
2009 7
2010 11
2011 20
2012 20
2013 26
2014 4
2015 12
2016 19
2017 17
2018 23
2019 25
2020 31
2021 14
Text availability
Article attribute
Article type
Publication date

Search Results

252 results
Results by year
Filters applied: . Clear all
Page 1
Yoga and physical exercise - a review and comparison.
Govindaraj R, Karmani S, Varambally S, Gangadhar BN. Govindaraj R, et al. Among authors: varambally s. Int Rev Psychiatry. 2016 Jun;28(3):242-53. doi: 10.3109/09540261.2016.1160878. Epub 2016 Apr 4. Int Rev Psychiatry. 2016. PMID: 27044898 Review.
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.
Beltran H, Prandi D, Mosquera JM, Benelli M, Puca L, Cyrta J, Marotz C, Giannopoulou E, Chakravarthi BV, Varambally S, Tomlins SA, Nanus DM, Tagawa ST, Van Allen EM, Elemento O, Sboner A, Garraway LA, Rubin MA, Demichelis F. Beltran H, et al. Among authors: varambally s. Nat Med. 2016 Mar;22(3):298-305. doi: 10.1038/nm.4045. Epub 2016 Feb 8. Nat Med. 2016. PMID: 26855148 Free PMC article.
EZH2-Targeted Therapies in Cancer: Hype or a Reality.
Eich ML, Athar M, Ferguson JE 3rd, Varambally S. Eich ML, et al. Among authors: varambally s. Cancer Res. 2020 Dec 15;80(24):5449-5458. doi: 10.1158/0008-5472.CAN-20-2147. Epub 2020 Sep 25. Cancer Res. 2020. PMID: 32978169 Review.
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM. Tomlins SA, et al. Among authors: varambally s. Science. 2005 Oct 28;310(5748):644-8. doi: 10.1126/science.1117679. Science. 2005. PMID: 16254181 Free article.
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction.
Zhao E, Maj T, Kryczek I, Li W, Wu K, Zhao L, Wei S, Crespo J, Wan S, Vatan L, Szeliga W, Shao I, Wang Y, Liu Y, Varambally S, Chinnaiyan AM, Welling TH, Marquez V, Kotarski J, Wang H, Wang Z, Zhang Y, Liu R, Wang G, Zou W. Zhao E, et al. Among authors: varambally s. Nat Immunol. 2016 Jan;17(1):95-103. doi: 10.1038/ni.3313. Epub 2015 Nov 2. Nat Immunol. 2016. PMID: 26523864 Free PMC article.
PRDM16 suppresses HIF-targeted gene expression in kidney cancer.
Kundu A, Nam H, Shelar S, Chandrashekar DS, Brinkley G, Karki S, Mitchell T, Livi CB, Buckhaults P, Kirkman R, Tang Y, Rowe GC, Wei S, Varambally S, Sudarshan S. Kundu A, et al. Among authors: varambally s. J Exp Med. 2020 Jun 1;217(6):e20191005. doi: 10.1084/jem.20191005. J Exp Med. 2020. PMID: 32251515 Free PMC article.
The polycomb group protein EZH2 is involved in progression of prostate cancer.
Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM. Varambally S, et al. Nature. 2002 Oct 10;419(6907):624-9. doi: 10.1038/nature01075. Nature. 2002. PMID: 12374981 Free article. Clinical Trial.
252 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page